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http:WHAT THIS PAPER ADDS
Because of the increasing number of endovascular procedures with ﬂuoroscopy, the corresponding high annual
dose for interventionalists, and the European directive (ICRP 2011) requiring a lower annual radiation dose to
the eye lens, additional dose-protecting measures are desirable for all operating staff during endovascular
aneurysm repair (EVAR). The effect of disposable radiation-absorbing surgical drapes has never been studied
before in a randomized controlled setting during endovascular procedures for AAA repair. This study evaluates
the effect of these drapes on the annual dose to the interventionalist and supporting staff.Objectives: Because of the increasing number of interventional endovascular procedures with ﬂuoroscopy and
the corresponding high annual dose for interventionalists, additional dose-protecting measures are desirable. The
purpose of this study was to evaluate the effect of disposable radiation-absorbing surgical drapes in reducing
scatter radiation exposure for interventionalists and supporting staff during an endovascular aneurysm repair
(EVAR) procedure.
Materials: This was a randomized control trial in which 36 EVAR procedures were randomized between execution
with and without disposable radiation-absorbing surgical drapes (Radpad: Worldwide Innovations &
Technologies, Inc., Kansas City, US, type 5511A). Dosimetric measurements were performed on the
interventionalist (hand and chest) and theatre nurse (chest) with and without the use of the drapes to obtain the
dose reduction and effect on the annual dose caused by the drapes.
Results: Use of disposable radiation-absorbing surgical drapes resulted in dose reductions of 49%, 55%, and 48%,
respectively, measured on the hand and chest of the interventionalist and the chest of the theatre nurse.
Conclusions: The use of disposable radiation-absorbing surgical drapes signiﬁcantly reduces scatter radiation
exposure for both the interventionalist and the supporting staff during EVAR procedures.
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In the last two decades endovascular aortic repair (EVAR)
has become the preferred treatment of abdominal aortic
aneurysm in patients suitable for EVAR.1 Despite pre-
cautions like a lead apron and thyroid shield, this increasing
use of EVAR and other endovascular interventions results in
considerable ﬂuoroscopic exposure of the intervening
physician.2 Low-energy scattered radiation scatters in all
directions from the patient during ﬂuoroscopy. This scatter
radiation is the main source of exposure for medical staffresponding author. J.A.W. Teijink, Catharina Hospital, Department of
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therlands.
il address: joep.teijink@catharinaziekenhuis.nl (J.A.W. Teijink).
-5884 2013 European Society for Vascular
. Published by Elsevier Ltd.
//dx.doi.org/10.1016/j.ejvs.2013.12.008
Open access under CC BY-NC-ND license.during ﬂuoroscopic procedures. Chronic exposure to low-
dose radiation confers a small risk of stochastic effects,
including malignant disease, skin damage, or eye prob-
lems.3e6 Recently the International Commission on Radio-
logical Protection (ICRP) reported that the equivalent dose
limit for the lens of the eye should be reduced from 150 to
20 mSv per year, averaged over a 5-year period, with no
year’s dose exceeding 50 mSv.7 This reduction in eye dose
limit and the applicable ALARA (as low as reasonably
achievable) principle demands additional dose-protecting
measures for operating staff performing EVAR procedures,
especially in a non-dedicated endosuite, where no addi-
tional dose-protecting measures, like lead ﬂaps or shields,
are available.
In cardiac interventions, it is shown that the use of sterile
disposable radiation-absorbing surgical drapes reduces
the radiation exposure of the medical staff, from 23% to
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these drapes in reducing scatter radiation exposure for
endovascular surgeons and supporting medical staff during
EVAR procedures.Figure 2. Position of the Radpad (type 5511A) during an endo-
vascular aneurysm procedure (top view).MATERIALS AND METHODS
From June 2012 to October 2012, 36 consecutive EVAR
procedures were randomly assigned to be performed with
or without the use of radiation-absorbing surgical drapes
(Radpad; Worldwide Innovations & Technologies Inc., Kan-
sas City, MO; US type 5511A), henceforth referred to as
“drape”. All patients with an indication for infrarenal
endovascular aortic aneurysm repair with a bifurcated stent
graft were included. The procedures were carried out by
three vascular surgeons with extensive experience in per-
forming EVAR procedures; no randomization of operators
was performed. During the procedures, standard radiation
protective measures were used for the interventionalist and
supporting staff, including a lead apron and thyroid shield.
The study was approved by the local ethics committee.
Positioning of the interventionalist and theatre nurse
during the EVAR procedures was standardized: the primary
operator (interventionalist) stood on the right side of the
patient near the pelvis, and the secondary operator stood
on the opposite side of the operating table. The theatre
nurse stood beside the secondary operator (Fig. 1). Both the
interventionalist and the theatre nurse wore dosimeters for
dosimetric measurements.
The drapes are the only commercially available, sterile,
disposable, lead-free surgical drapes. They have a uniform
thickness of a few millimeters and contain bismuth and
barium. The dose-reducing function is comparable to 0.4e
0.8 mm lead (Pb) depending on the kilovoltage used toFigure 1. Schematic overview of the position of the drapes,
medical staff, and C-arm during the endovascular aneurysm pro-
cedure. 1 ¼ interventionalist; 2 ¼ assisting interventionalist;
3 ¼ theatre nurse.make the image (90e60 kV). In the “drape” group two
drapes were used. These sterile drapes were interposed
between the patient and interventionalist, outside the ra-
diation ﬁeld, and positioned above the normal sterile
surgical drape after the femoral operative site had been
prepared. Positioning of the drapes is shown in Figs. 1
and 2.
All procedures were performed in a non-dedicated
endosuite, where no additional dose-protecting measures,
like lead ﬂaps or shields, were available. A mobile angio-
graphic C-arm was used (Axiom Artis U; Siemens, Munich,
Germany) for ﬂuoroscopic imaging. Both the milliAmpere
(mA), which is the quantity of produced radiation, and the
peak kilovoltage (kVp), which is a quantity of the beam
penetrability, were kept in a range between 2.1e2.5 mA
and 60e90 kVp for all procedures. The image intensiﬁer was
positioned above the abdomen of the patient. Scatter ra-
diation was measured on the left chest of the inter-
ventionalist and the theatre nurse using a calibrated
electrical personal dosimeter (EPD, DoseAware system,
Philips Medical Systems, Eindhoven, The Netherlands).
Scatter radiation was measured on the base of the left ring
ﬁnger of the primary operator with a calibrated ring
dosimeter (Nuclear Research and consultancy Group, Arn-
hem, The Netherlands).
For each procedure the start and end time of the pro-
cedure, the total ﬂuoroscopy time(s), the dose area product
(DAP) (cGycm2), and dose (mSv) were registered. Since start
and end times of the procedures were registered, the dose
could be determined after the procedure by selecting the
time frame in which the procedure was performed using
special software (DoseManager, Philips Medical Systems,
Eindhoven, The Netherlands). Since the path length differ-
ence for the scattered radiation to chest and eye is just a
few centimeters, it can be assumed that the measured dose
on the chest is comparable to the dose on the eye lens. The
ring dosimeter was sent monthly to the Nuclear Research
and consultancy Group for evaluation.
By dividing the measured dose by the DAP value of each
procedure, compensation for the inequalities due to
different interventionalist, ﬂuoroscopic times, and body
Table 1. Procedural data.
Control group Drape cohort p
Number of procedures 18 18
Operator
A 9 4
B 7 10
C 2 4
Fluoroscopy time (s) 841
(208e1089)
669
(515e1385)
DAP (cGycm2) 9458
(1497e16510)
8638
(2896e22991)
0.613
Dose per procedure
in front of apron
chest operator (mSv)
167.7  134.1 73.0  50.9 0.008a
Dose/DAP per
procedure chest
operator (mSv/Gycm2)
0.023 0.011 0.023a
Dose per
procedure on
hand operator (mSv)
470.3  222.4 236.8  193.1 0.002a
Dose/DAP per
procedure
hand operator
(mSv/Gycm2)
0.050 0.025 0.000a
Dose per procedure
in front
of apron chest
theatre
nurse (mSv)
41.9  74.8 21.4  33.3 0.29
Dose/DAP per
procedure
chest theatre nurse
(mSv/Gycm2)
0.006 0.003 0.086
Data are expressed as number or mean (range) and mean  SD.
a Signiﬁcant difference between control group and drape cohort.
270 C. Kloeze et al.mass index (BMI) of the patients was performed. Second,
the mean dose reduction per procedure due to the use of
the drapes was calculated.
Data are presented as mean (range), mean  SD, and
percentages. A skewness test was performed to investigate
whether data were normally distributed. A Student t-test
was performed to determine whether dosimetric mea-
surements with the use of the drapes were signiﬁcantlyFigure 3. Overview mean dose (mSv) on chest and hand of the
operator and chest of theatre nurse during an endovascular
aneurysm procedure with (Drape group) and without (Control
group) the use of the drapes.different from those without the drapes. A value of p .05
was considered statistically signiﬁcant. The analyses were
performed using SPSS (Version 15.0, IBW Company, Chi-
cago, IL, USA). The annual doses for both the inter-
ventionalist and the theatre nurse were calculated by
multiplying the mean dose per procedure by the number of
procedures performed annually per surgeon. It was
assumed that each interventionalist and supporting staff
members were present during 80 EVAR procedures annu-
ally. Since all medical staff wear a lead apron and thyroid
shield during the procedure, the measured dose on the
chest can be reduced ﬁvefold to obtain the actual dose
received.12
RESULTS
All data were successfully collected during the 36 EVAR
procedures. An overview of the procedural data is given in
Table 1. Dosimetric data are normally distributed. The mean
DAP was 9548 cGycm2 and 8638 cGycm2 in the control
group and “drape” cohort respectively (p ¼ .613).
During a single EVAR procedure, the mean dose
measured on the chest of the interventionalist was
167.7 mSv in the control group compared with 73.0 mSv
(p ¼ .008) in the drape group. The mean dose measured on
the hand of the interventionalist was reduced from
470.3 mSv to 236.8 mSv (p ¼ .002) with the use of a drape. A
dose reduction due to the use of the drapes was found at
the chest of theatre nurse as well (42.3 mSv to 21.4 mSv);
however, this difference did not reach signiﬁcance (p ¼ .29)
(Table 1, Fig. 3).
This results in a decrease in the annual dose on the chest
of the interventionalist from 13.4 mSv to 5.8 mSv (55%); the
annual dose on the hand of the interventionalist from
37.6 mSv to 18.9 mSv (49%); and the annual dose on the
chest of the theatre nurse from 3.4 to 1.7 mSv (48%). Since
it can be assumed that the dose measured in front of the
lead apron on the chest is representative for the dose on
the eye lens, the eye lens dose of the interventionalist will
reduce from 13.4 mSv to 5.8 mSv, which corresponds to a
dose reduction of 55%.
DISCUSSION
This randomized trial in humans shows that the use of a
sterile lead-free disposable drape is feasible during EVAR
procedures and signiﬁcantly reduces the radiation exposure
of the intervening endovascular surgeons. The Radpad
drape is simple to position and does not interfere with the
EVAR procedure. There were no safety issues, prolonged
ﬂuoroscopy times or complications associated with the use
of the drape. The protective lead-free drape we used in the
study has been tested before in phantoms showing a radi-
ation exposure reduction varying from 14% up to 94%,
depending on the amount of radiation-absorbing material
used in the drape, distance, and position of the measure-
ments and additional protection measures.13e17 In humans
the drape has been tested during percutaneous coronary
angiography,18 complex coronary interventions,8 pectoral
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cardiac resynchronization therapy9 all showing a signiﬁcant
reduction in radiation exposure. The drape had not previ-
ously been tested during abdominal procedures like EVAR.
The risk of radiation-induced lens opacities among inter-
ventional cardiology and radiology workers is higher than
suspected, and the lowest cataractogenic dose in humans
seems to be substantially less than previously thought.6,19e21
In 2011 the ICRP statement prescribed new restrictions,
reducing the annual eye dose limit from 150 to 20 mSv.7 The
number of endovascular procedures performed by endo-
vascular surgeons has increased signiﬁcantly in recent years.
As a result of this increase, the endovascular surgeon is
cumulatively exposed to radiation and is in danger of
exceeding the new limitations for eye lens dose. Our study
shows that a sterile lead-free disposable drape can reduce the
chest and eye lens dose to the operator by 55%.
The measured dose reduction on the chest of the theatre
nurse was not signiﬁcant. This can be explained by the large
standard deviation in the received dose of the theatre nurse
during an EVAR procedure. Since the nurse is handing over
the instruments during the procedure, the angle of the
dosimeter to the source of radiation (the patient) may vary
considerably per procedure. This is not the case for the
primary operator, since the operator is standing in the same
position or angle to the patient most of the time.
Since we were interested in the dose reduction caused by
the use of a sterile lead-free disposable drape during an
average infrarenal EVAR procedure in our hospital, we
included all EVAR procedures in the period June 2012 to
October 2012. Because of variation in complexity of the
EVAR procedures, an expected large standard deviation in
used ﬂuoroscopic time and DAP values was found. Further,
three different operators performed the 36 procedures. To
correct or compensate for this variability all measured
doses were divided by the DAP value of the procedure. This
results in an objective percentage of the mean dose
reduction due to the use of these drapes.
This is a single center, randomized study with three experi-
enced operators involved. We think that the results are
representative for many other centers performing EVAR pro-
cedures in a non-dedicated endosuite without additional ra-
diation protection measures like a lead acrylic radiation
protective shield in the ceiling or lower body protective lead
panels mounted on the operating table. When EVAR pro-
cedures are performed in a dedicated endosuite, with the
above-mentioned additional radiation protection, the dose-
reducing effect of the drapes is expected to be lower because
of the dose-reducing effect of the shield and/or panels.
An alternative for the use of scatter radiation protective
drapes is the use of protective eyewear to reduce the eye
dose, since they are reusable and less expensive.22 How-
ever, these glasses could cause discomfort and a drape
protects not only the eyes, but the whole upper body of the
operator. For example, we also found a reduction in hand
dose of 49%. The drape not only protects the operator but
also the other supporting staff; a mean dose reduction for
the theatre nurse of 48% was achieved. Therefore, becauseof the ALARA principle, we prefer the use of the scatter
radiation protective drapes.
Each hospital has to weigh the amount of dose reduction
with the costs of the drapes and consider other possible
dose-protecting measures like lead glasses, lead panels, and
lead shields. The dose-reducing effect of all these measures
depends strongly on the set up in the operating room, that
is the position of the medical staff relative to the patient
(and scatter radiation) and angulations of the C-arm. A
drawback of the lead-free drapes is the fact that they are
disposable, and therefore for each procedure additional
costs are made (approximately 75 euros per drape).
Our study has certain limitations. First, operators were
not blinded with respect to the presence of a protective
drape since no sham drape was used in procedures in the
control group. However, it is unlikely that this circumstance
will inﬂuence the results of this study.
Further, in this study, only patients with an infrarenal
aortic repair were included. More complex and lengthier
procedures like fenestrated/branched EVAR procedures
were excluded. Since the position of the medical staff
relative to the source of radiation is the same during
standard and complex EVAR procedures, we can assume
that the relative reduction in doses to the interventionalist
and theatre nurse is approximately equal.
CONCLUSION
Endovascular interventionalists are more frequently
exposed to radiation due to the increase in EVAR and other
endovascular procedures which employ ﬂuoroscopy. This
study showed that the use of disposable, radiation-
absorbing drapes signiﬁcantly reduces scatter radiation
exposure for the interventionalist, resulting in a lower risk
of the stochastic effects of radiation. We also showed that
staff during EVAR procedures are additionally protected by
the use of these drapes. In adherence to the ALARA prin-
ciple and the knowledge of the stricter ICRP guidelines,
utilization of these drapes during EVAR procedures is rec-
ommended when performed in a non-dedicated endosuite.
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